ID

11732

Beschrijving

The purpose of the study is to assess the efficacy (prevention of vascular events) and safety (especially bleedings) of Ticagrelor (AZD6140) compared with Clopidogrel, both given on top of low dose aspirin, in Asian/Japanese patients with acute coronary syndrome and a planned percutaneous coronary intervention (PCI).

Trefwoorden

  1. 28-07-15 28-07-15 -
  2. 21-11-15 21-11-15 -
Geüploaded op

28 juli 2015

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY-NC 3.0 Legacy

Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Criteria: Study to Assess Safety and Efficacy of Ticagrelor (AZD6140) Versus Clopidogrel in Asian/Japanese Patients With Non-ST or ST Elevation Acute Coronary Syndromes (ACS)

Eligibility criteria

  1. StudyEvent: ODM
    1. Eligibility criteria
Inclusion Criteria
Beschrijving

Inclusion Criteria

Provision of signed informed consent
Beschrijving

Provision of signed informed consent

Datatype

boolean

Alias
UMLS CUI-1
C0021430
Index event of ST segment elevation ACS
Beschrijving

Index event of non-ST or ST segment elevation ACS

Datatype

boolean

Alias
UMLS CUI-1
C1536220
Index event of non-ST segment elevation ACS
Beschrijving

Index event of non-ST segment elevation ACS

Datatype

boolean

Alias
UMLS CUI-1
C3537184
Exclusion criteria
Beschrijving

Exclusion criteria

Index event is an acute complication of percutaneous coronary intervention
Beschrijving

Index event is an acute complication of percutaneous coronary intervention

Datatype

boolean

Patient has undergone Percutaneous Coronary Intervention (PCI) after the index event before the first dose of study treatment
Beschrijving

Patient has undergone Percutaneous Coronary Intervention (PCI) after the index event before the first dose of study treatment

Datatype

boolean

Alias
UMLS CUI-1
C1532338
Oral anticoagulation therapy that cannot be stopped
Beschrijving

Oral anticoagulation therapy that cannot be stopped

Datatype

boolean

Alias
UMLS CUI-1
C0003281
The conditions associated with increased risk of bradycardiac events
Beschrijving

The conditions associated with increased risk of bradycardiac events

Datatype

boolean

Alias
UMLS CUI-1
C0428977

Similar models

Eligibility criteria

  1. StudyEvent: ODM
    1. Eligibility criteria
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
Inclusion Criteria
Informed consent
Item
Provision of signed informed consent
boolean
C0021430 (UMLS CUI-1)
STEMI
Item
Index event of ST segment elevation ACS
boolean
C1536220 (UMLS CUI-1)
NSTEMI
Item
Index event of non-ST segment elevation ACS
boolean
C3537184 (UMLS CUI-1)
Item Group
Exclusion criteria
PCI complication
Item
Index event is an acute complication of percutaneous coronary intervention
boolean
PCI
Item
Patient has undergone Percutaneous Coronary Intervention (PCI) after the index event before the first dose of study treatment
boolean
C1532338 (UMLS CUI-1)
anticoagulation therapy
Item
Oral anticoagulation therapy that cannot be stopped
boolean
C0003281 (UMLS CUI-1)
Bradycardia
Item
The conditions associated with increased risk of bradycardiac events
boolean
C0428977 (UMLS CUI-1)

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial